ID   CaB34
AC   CVCL_E9XT
DR   GEO; GSE277693
RX   DOI=10.3390/cells14110819;
CC   Population: Caribbean.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): DOI=10.3390/cells14110819
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13,14
ST   D16S539: 10,12
ST   D5S818: 8,12
ST   D7S820: 8,10
ST   TH01: 5,7
ST   TPOX: 6,11
ST   vWA: 16,17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
CH   CVCL_E9XU ! CaB34-CF
//
RX   DOI=10.3390/cells14110819;
RA   Wright, Jessica A.
RA   White, Stephanie D.
RA   Frame, Gavin
RA   Bosiljkov, Ana
RA   Khan, Shahbaz
RA   Haas, Roni
RA   Yang, Qian
RA   Sheng, Min-Zhi
RA   Huang, Xiao-Yong
RA   Higgins, Geoff Stuart
RA   Mills, Ian
RA   Downes, Michelle R.
RA   Vesprini, Danny
RA   Chung, Hans Tse-Kan
RA   Screaton, Robert A.
RA   Leong, Hon S.
RA   Boutros, Paul Christopher
RA   Kislinger, Thomas
RA   Liu, Stanley K.
RT   "A novel primary cell line model of localized prostate cancer and
RT   radioresistance -- a role for nicotinamide N-methyltransferase.";
RL   Cells 14:819.1-819.20(2025).
//